ROCKET PHARMACEUTICALS, INC.
RCKTWN/A
NASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 31, 2026
17wMarket Overview
Stock performance and key metrics
RCKTW News
Catalyst Timeline
1 upcoming, 1 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
RP-L102 | Phase 2 | Fanconi Anemia Complementation Group A | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply